News | November 14, 2025
Novartis is the only pharmaceutical company with a dedicated commercial RLT portfolio
New site expands manufacturing footprint to meet future demand; ensures continued on-time delivery rate of >99.9% to patients across western US, Alaska and Hawaii
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
Agreements mark a major victory in the President’s long-term pledge to lower prescription drug costs for Americans
Enabling a new era in minimally invasive obesity treatment across Europe
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
